Michael Scolaro

Michael Scolaro

Aug 25, 2017

Group 6 Copy 152
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

MyHealthEd

Each child deserves quality comprehensive sexual health education. No child is the same, so why should...

Do fungi exposed to toxic waste produce novel antimicrobial agents?

We've discovered a few new mushrooms thriving in this harsh environment of land-disposed sewage sludge in Snoqualmie...

Mapping Addiction

Addiction and drug dependence are preventable and treatable diseases. Understanding the neurophysiological...

Backer Badge Funded